Human ochratoxicosis and nephropathy in Egypt: A preliminary study

Abstract

This preliminary study was designed in a trial to delineate the size of the problem of ochratoxicosis and its relation to genesis of lesions mounting to end stage renal disease (ESRD) or urothelial tumors in Egypt. This study comprised five groups of patients having renal diseases of different presentations; they are: patients with (ESRD) under conservative medical treatment (group 1), patients with (ESRD) under treatment with regular hemodialysis (group 2), renal allograft recipients (group 3), patients with nephrotic syndrome (group 4) and patients with urothelial tumors (group 5). In addition, two reference groups: potential related donors for renal transplantation (group 6) and healthy control with negative family history of renal disease (group 7).

For all groups, laboratory, radiological and histopatho-logical evaluation of kidney status were carried out coupled with determination of ochratoxin A level in serum, in urine and in biopsy specimens of patients with urothelial tumors.

High ochratoxin serum levels were found in patients with ESRD (groups 1 and 2) (P50.01), higher serum levels were detected in the group without dialysis (group 1) in comparison with the reference groups possibly due to ochratoxin. A clearance by dialysis. Ochratoxin A was detected in serum and urine of renal transplant recipients (group 3) (P50.01) and especially higher levels were found in patients with nephrotic syndrome (group 4) (P50.001). For the group with urothelial tumor (group 5), positive serum, urine and tissue biopsy specimens for ochratoxin levels were found (P50.01).

The results could lead to the conclusion that ochratoxin A could be correlated to the genesis of renal disease leading to (ESRD) or causing urothelial cancer. A thorough and in depth study of the problem of ochratoxicosis and renal disease causation in Egypt is now recommended.

Keywords

mycotoxin ochratoxin A kidney disease

Get full access to this article

View all access options for this article.

References

Maaroufi K et al. Human nephropathy related to ochratoxin A in Tunisia . J Toxicol Toxin Reviews 1996; 15: 223-237 .

Van Der Merwe KJ et al. Ochratoxin A, a toxic metabolite produced by Aspergillus ochraceus . Nature 1965; 205: 1112-1113 .

Simon P. Ochratoxin and kidney disease in the human . J Toxicol Toxin Reviews 1996; 15: 239-249 .

Krogh P , Hald B , Plestina R , Ceovic S. Balkan (endemic) nephropathy and food born ochratoxin A: a preliminary result of a survey of foodstuffs . Acta Path Microbiol Scand Sec B 1977; 85: 238-240 .

Bauer J , Gareis M. Ochratoxin A in the food chain . Animal Research & Development 1991; 33: 80-97 .

Krogh P. Ochratoxins in food. In Mycotoxin in food P. Krogh (ed.) New York: Academic Press , pp.. 97-121, 1987.

Petkova-Bocharova T , Chernozemsky IN , Castegnaro M. Ochratoxin A in human serum in relation to Balkan Endemic Nephropathy and urinary system tumours in Bulgaria . Food Addit Contam 1988; 5: 299-301 .

Kuiper Goodman T , Scott PM. Risk assessment of the mycotoxin ochratoxin A . Biomed Environ Sci 1989; 2: 179-248 .

Breitholtz A , Olsen M , Dahlback A , Hult K. Plasma Ochratoxin A levels in three Swedish populations surveyed using an ion-pair HPLC technique . Food Addit Contam 1991; 8: 183-192 .

10.

Creppy EE et al. Human ochratoxicosis in France. In Mycotoxins, Endemic Nephropathy and Renal Tumours. Castegnaro M , Plestina R , Dirheimer G , Chernozemsky IN and Bartsch M (eds.). Lyon, IARC Scientific publication , 115; pp. 145-151, 1991.

11.

Creppy EE et al. Ochratoxin A. Human ochratoxicosis and its pathologies. Creppy EE , Castegnaro M , Dirheimer G (eds.) Colloque INSERM/John Libbey Eurotext Ltd, 231: pp. 147-158, 1993.

12.

Maaroufi K et al. Ochratoxin A in human serum in relation to nephropathy in Tunisia . Human & Exp Toxicol 1995; 14: 609-615 .

13.

Krogh P. Mycotoxic nephropathy . Adv Vet Sci Comp Med 1976; 20: 147-170 .

14.

Pavlovic M , Plestina R , Krogh P. Ochratoxin A contamination of foodstuffs in an area with Balkan (Endemic) Nephropathy . Acta Path Microbiol Scand Sect B 87, 1979; 87: 243-246 .

15.

Speijers GJA , Van Egmond HP. Worldwide ochratoxin A levels in food and feeds. In Human ochratoxicosis and its pathologies, ( Creppy EE , Castegnaro M , Dirheimer G (eds.) Paris, Colloque Inserm, 231 : 85-100, 1993.

16.

El Matri A. L'insuffisance rénale dans les pays Arabes . Colloque International Ochratoxicoses et néphropathies, situation endémique

Monastir

25-26 Nov, p. 11-11 , 1994.

17.

Achour A , El May M. Les néphropathies chroniques dans le centre Tunisien . Colloque international. Ochratoxicoses et néphropathies, situation endémique, Monastir 25-26 Nov, p. 12-12 , 1994.

18.

Wing AJ. Causes of end stage renal failure. In: Cameron S , Davidson AM , Gründeld JP , Kerr D , Ritz E (eds.). Oxford textbook of clinical Nephrology, Oxford Medical Publications , 2: pp. 1227-1236, 1992.

19.

Di Parlo N et al. Inhaled mycotoxins lead to acute renal failure . Neph Dial Transplant 1994; 9; Suppl 4: 116-120 .

20.

Krogh P. Role of ochratoxin in disease causation . Food Chem Toxic 1992; 30: 213-224 .

21.

Castegnaro M , Chernozemsky IN , Hietanen E , Bartsch H. Are mycotoxins risk factors for endemic nephropathy and associated urothelial cancers ? Arch Geschwulstforsch 1990; 60: 295-303 .

22.

Evrin PE , Wibell L. The serum levels of urinary excretion of β2-microglobulin in apparently healthy subjects . Scand J Clin Lab Invest 1972; 29: 69-74 .

23.

Frank HK. Food contamination by ochratoxin A in Germany. In: M Castegnaro , R Plestina , G Dirheimer , IN Chernozemzky , H Bartsch (eds.). Mycotoxins, Endemic Nephropathy and Urinary tract tumor. Lyon: International Agency for Research on Cancer , 115: pp. 77-81, 1991.

24.

Bach PH. The modulation of mycotoxin exposure in domestic animals and man: Can we affect what we can't control? Markers for mycotoxin nephrotoxicity in domestic animals and man. In: EE Creppy , M Castegnaro , G Dirheimer (eds.). Human Ochratoxicosis and its pathologies. Paris, Editions Inserm , 231: pp. 43-49, 1993.

25.

Hall PW. Balkan Endemic Nephropathy: more questions than answers . Nephron 1992; 62: 1-5 .

26.

Delacruz L , Bach PH. The role of ochratoxin A metabolism and biochemistry in animal and human nephrotoxicity . J Biopharm Sci 1990; 1: 277-304 .

27.

Mihatsch MJ et al. System Karyomegaly associated with chronic interstitial nephritis. A new disease entity ? Clin Nephrol 1979; 12: 54-62 .

28.

Godin M et al. Karyomegalic interstitial nephritis . Am J Kidney diseases 1996; 27: 166-166 .

29.

Carlton WW , Krogh P. Ochratoxins, a review . In: Shimoda W. Conference on mycotoxins in animal feeds and grains related to animal healths. National Technical Information Service, Springfield, pp. 166-288 , 1979.

30.

Krogh P et al. Experimental porcine nephropathy. Change of renal function and structure induced by OTA-contaminated food . Acta Pathol Microbiol Scand, Sect A, Suppl 1974; 246-246 .